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ABSTRACT 
 
ASSESSMENT OF FEASIBILITY AND UTILITY OF ROTATIONAL CORONARY 
ANGIOGRAPHY IN ROUTINE PRACTICE 
 
 
Background: Coronary angiography is probably the most common invasive diagnostic 
procedure done these days and the workload of operators and staff in the catheterization 
laboratory is increasing rapidly. The overall number of projections is limited by time, 
safety and cost considerations and the usual compromise is to obtain a limited number 
of projections for each coronary artery. Rotational coronary angiography was designed 
to overcome some of these problems. There have been a few studies worldwide on this 
new technology and to the best of our knowledge, none from India. Hence, the present 
study was undertaken to test the feasibility of performing rotational angiography in a 
routine practice, in a busy cardiac catheterization laboratory setting.  
 
Methods: Rotational angiography was performed on patients admitted for coronary 
angiography, including those with renal dysfunction and/or left ventricular dysfunction. 
Amount of contrast used, radiation dose, fluoroscopy time, pre and post-angiography 
glomerular filtration rate (GFR) (ml/min/1.73m2) were studied to assess feasibility and 
safety of the procedure. Subgroup analysis on patients with compromised renal function 
and poor left ventricular ejection fraction (LVEF) prior to the procedure was done. The 
results were analyzed using appropriate statistical methods. 
 
Results: The mean total contrast volume used for rotational coronary angiography in 
this study was 22.44 ± 5.16 ml (n = 64). This was significantly less (p < 0.05) as 
compared with the mean total contrast volume used for standard coronary angiography 
obtained from unpublished data in Christian Medical College, Vellore which was 38.16 ± 
7.7 ml (n = 25). The mean Dose Area Product (DAP) in this study was 20.64 ± 7.18 
Gycm2. This was compared with data for standard angiography obtained from previously 
published data from Christian Medical College, Vellore which was 55.86 ± 5.75 Gycm2. 
The difference between the two was statistically significant (p < 0.0001). There was a 
positive correlation of body mass index and fluoroscopy time with DAP. There was a 
reduction of fluoroscopy time with case numbers and hence a definite learning curve 
was demonstrated. In patients with LVEF < 50% and/or GFR < 60ml/min/1.73m2, there 
was no significant worsening of GFR after rotational angiography. None of the patients 
developed contrast induced nephropathy. Rotational angiography provides just as good 
image quality and anatomic information as a standard coronary angiography. This was 
assessed by the primary operator and a consultant cardiologist, who independently 
reviewed the images. 
 
Conclusion: Rotational coronary angiography offers a significant reduction in contrast 
volume and radiation dose when compared to standard coronary angiography while 
providing good image quality and anatomic information. It appears to have a definite role 
in patients at risk for developing contrast induced nephropathy
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INTRODUCTION 
 
Cardiovascular disease (CVD) was the leading cause of death globally in 2005, 
responsible for 17.5 million deaths, more than 80% of which occurred in low and 
middle-income countries (LMIC) 1.  
By 2030, the number of cardiovascular deaths is projected to increase to 23 
million, with about 85% occurring in these countries2. Already, CVD is the leading 
cause of death in China3 and India4, the world’s 2 most populous countries. The 
CVD burden suffered by many LMIC now exceeds that suffered by many high 
income countries. CVD has a huge economic impact on individuals, households, 
and countries. The effects are particularly marked in LMIC, where CVD more 
frequently affects those of working age, and for this reason contributes 
disproportionately to lost potential years of he  deaths occur before the age of 70 
years, compared with just one-quarter in high-income countries5. Similarly, in 
India, CVD mortality in the working age population (30 to 59 years) is twice that 
in the U.S.6. 
Recent estimates of foregone gross domestic product (GDP) associated with 
CVD and diabetes for 23 LMIC highlight how such illnesses can significantly 
impair economic growth7. It was estimated that the aggregate loss in GDP across 
these countries in 2006 as a consequence of these diseases was $6.8 billion, 
with China, India, and Russia each incurring annual losses of over $1 billion. In a 
recent study in rural Andhra Pradesh, India, CVD was found to be the leading 
cause of death; however, less than one-sixth of those with a previous 
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cardiovascular event (mostly myocardial infarction) were receiving antiplatelet 
therapy8.  
India is experiencing an alarming increase in heart disease.  The World Health 
Organization (WHO) estimates that 60 percent of the world’s cardiac patients will 
be Indian by 2010. This rise in CVD may be due to metabolic differences in 
response to Western lifestyle of higher fat diets and lower levels of activity. 
Diabetes is a major health issue; India has 31.6 million diabetics, more than any 
other country. Indians have exaggerated insulin sensitivity in response to the 
Western life-style pattern. Furthermore, the proportion of calories derived from 
fat, much of which comes from dairy products, is significantly higher in India than 
in other parts of the developing world9.  
At Christian Medical College (CMC), Vellore, admissions due to CHD in a non-
government hospital steadily increased from 4% in 1960 to 33% in 198910. 
Proportional to the increase in incidence in coronary artery disease and hospital 
admissions for the same, there has also been a marked increase in the number 
of patients undergoing coronary diagnostic and interventional procedures.  In 
1995, there were approximately 600 angiographies and 250 angioplasties 
whereas in 2008, there were 2100 angiographies and 1300 angioplasties. 
Coronary angiography is the most ubiquitous invasive diagnostic procedure in 
the industrialized world, the frequency of patient exposure to multiple coronary 
angiograms is common, and the workload of operators and staff in the 
catheterization laboratory is increasing rapidly. 
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Coronary angiography actually consists of a limited number of predetermined 
projections, individually adjusted by the operator according to the presumed 
geometry and orientation of the stenoses. The choice of the views is thus in part 
arbitrary and partly follows a trial and error process that should be applied to 
each lesion to get optimal visualization. However, because the overall number of 
projections is limited by time, safety and cost, the usual compromise is to obtain 
four to seven projections for the left and two to four for the right coronary artery. 
The resulting gap between adjacent projections, and thus the potential deviation 
from the optimal angle of observation, will range from 30° to >90° when only two 
projections are used. This gap can lead to serious underestimation of the severity 
of the stenosis and of its length. 
Rotational coronary angiography was designed to overcome these problems and 
provide a panoramic representation of the coronary tree as a rotating image 
conveying complete three-dimensional information, giving a better insight into the 
coronary tree and permitting a more accurate reconstruction of complex 
anatomies. There have been a few studies worldwide on this new technology and 
to the best of our knowledge, none from India. 
Hence, the present study was undertaken to test the feasibility of performing 
rotational angiography in a routine practice, in a busy cardiac catheterization 
laboratory setting.  
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AIMS AND OBJECTIVES 
 
Aim:  
The aim of this study is to assess the feasibility of rotational coronary 
angiography in routine practice. 
 
Objectives: 
1. To perform rotational angiography instead of standard angiography in 
consecutive patients undergoing coronary angiography. 
2. To assess the radiation dose and contrast volume used in rotational 
coronary angiography as compared to standard coronary angiography. 
3. To determine the occurrence of contrast induced nephropathy in patients 
undergoing rotational coronary angiography. 
4. To assess renal function before and after rotational angiography, in 
patients with pre-existing renal and/or LV dysfunction. 
5. To assess the image quality and adequacy of anatomic information 
provided by rotational angiography for further management. 
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REVIEW OF LITERATURE 
 
History of coronary angiography: 
 
Among the first to describe and work on coronary arteries was Leonardo da Vinci 
(1452–1519). The closed circulation of blood was described one hundred years 
later by William Harvey (1628) (Exercitatio anatomica de motu cordis et 
sanguinis in animalibus).  
The cardiologist, William Heberden (1710–1801) was the first to exactly 
recognize and describe angina in his publication “Some account of a disorder in 
the breast”; it appeared in the College of Physicians on July 20, 1768. The 
American cardiologist James B. Herrick (1861–1954) made an important 
contribution to the analysis of coronary sclerosis in the paper “Clinical features of 
certain obstructions of the coronary arteries”. He concluded in 1912 that “a slow, 
gradual narrowing of coronary vessels is a possible cause, permitting the heart to 
adapt to the new conditions, and that a severe obstruction of a vessel must not 
necessarily lead to death”. He brought this theory to Europe in 1918, propagating 
it widely; he also created the term “heart attack”. Herrick described in 1918 the 
electrocardiographic changes after ligation of the coronary vessels.   
The first coronary heart catheterization was performed in 1929 by Werner 
Forssmann in his famous “self-experiment”. Forssmann worked with a catheter 
for bladders, Charrière 4, which he introduced approx. 65 cm deep into the right 
auricle, applying the jugular vein. His achievement was scarcely noticed so that 
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Forssmann abandoned the idea of catheterization. The lung specialist André 
Cournand, however, was fascinated by the procedure: together with the 
cardiologic pediatrician Dickinson Richards, he successfully repeated in 1941 the 
trial of Forssmann. The catheter was pushed into the right auricle; by 1942, they 
were able to push it further and place it into the right ventricle.  
The rapid development of angiography in the early 1950s led to the ardent wish 
for a depiction of coronary arteries by means of intervention. Contrast material 
was injected into the aorta, flowing from there into the coronary vessels, 
resulting, however, quite often in an insufficient filling of contrast material11.  
Mason Sones (1918–1985), a cardiologic pediatrician, solved the problem: in 
performing an angiogram following the well-known technique on a 26-year-old 
man, the catheter slipped inadvertently from the aorta into the right coronary 
artery. By this, all contrast material was injected and went into the right coronary 
artery instead of the aorta. Monitoring of catheterization was not known at that 
time, yet the mishap of the wrongly performed injection remained without 
consequences, no damage was observed. Mason Sones immediately grasped 
the important consequence of the situation: he replaced supra-aortic injections by 
selective coronary angiography, that is, by injecting smaller amounts of contrast 
medium into the relevant coronary vessel. This was a breakthrough, and the 
technique became a routine procedure in the Cleveland Clinic in 1959. 
Lastly, no history of the development of coronary arteriography would be 
complete without acknowledging the important contributions of Drs. Judkins12 
and Amplatz13. Both of these radiologists used the Seldinger percutaneous 
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technique14 to gain access to the femoral artery. Independently, they designed 
preformed catheters, the conformity of which sought out the ostia of either the left 
or right coronary artery as well as facilitating access to the left ventricle. It was 
these preformed catheters that made successful engagement of the coronary 
ostia a much easier process that required far less training than the Sones’ 
technique, which required a brachial cut down, requiring much more time to 
become skillful. Undoubtedly, this facilitated the widespread dispersion of 
angiography as a diagnostic technique throughout the cardiology and radiology 
communities.  
 
                     
Figure 1. Cine frame from the first selective coronary arteriogram taken by F. Mason Sones, MD, 
on October 30, 1958. 
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Indications for coronary angiography: 
 
The various current indications for coronary angiography are summarized 
comprehensively in the AHA/ACC guidelines on coronary angiography15. The 
most frequent indication is the further evaluation of patients in whom the 
diagnosis of coronary atherosclerosis is almost certain and in whom anatomic 
correction by means of coronary bypass surgery or percutaneous coronary 
intervention is contemplated. Angiographic evaluation of coronary anatomy in 
such patients provides the crucial information needed to select the most 
appropriate treatment strategy - catheter intervention, bypass surgery, or medical 
therapy. Included in this category are patients with stable angina pectoris 
refractory to medical therapy. Even asymptomatic patients with noninvasive 
evidence of myocardial ischemia also benefit from revascularization and are thus 
candidates for coronary angiography16. In patients with unstable angina, more 
than two thirds of such patients will come to angiography within 6 weeks of 
presentation anyway owing to ongoing clinical symptoms or a positive exercise 
test17, 18. Patients with acute myocardial infarction routinely undergo immediate 
coronary angiography followed by same-procedure primary angioplasty19. 
A second group of indications for coronary angiography consists of patients in 
whom the presence or absence of coronary artery disease is unclear15. This 
includes patients with troublesome chest pain syndromes but ambiguous 
noninvasive test results, patients with unexplained heart failure or ventricular 
arrhythmias, survivors of out-of-hospital cardiac arrest20, patients with suspected 
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or proven variant angina21, and patients with risk factors for coronary artery 
disease who are being evaluated for major abdominal, thoracic, or vascular 
surgery22. This category also includes patients scheduled for correction of 
congenital or valvular pathology. Patients with congenital defects such as 
tetralogy of Fallot frequently have anomalies of coronary distribution that may 
lead to surgical complications if unrecognized23, whereas patients older than age 
45 years with valvular disease may have advanced coronary atherosclerosis 
without clinical symptoms. Although younger patients with valvular disease are 
commonly operated on without prior coronary angiograms, given the 
extraordinary low risk of diagnostic catheterization and the potential benefit of 
knowing the coronary anatomy, most surgical center personnel believe it is best 
to perform a preoperative diagnostic catheterization to identify (and then correct) 
significant coronary lesions, to provide the best and safest outcome during 
concurrent valve replacement24. 
Finally, coronary angiography is frequently performed when a patient develops 
recurrent angina after coronary intervention or after bypass surgery (to detect 
vein graft failure, which might require catheter intervention or reoperation). 
Routine follow-up angiography 6 months after catheter intervention is not 
indicated clinically, but may play an important role in the research evaluation of 
new technologies or drug therapies targeted at reducing restenosis25. 
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Standard coronary angiography: 
 
Coronary angiography actually consists of a limited number of predetermined 
projections, individually adjusted by the operator according to the presumed 
geometry and orientation of the stenoses. The choice of the views is thus in part 
arbitrary and partly follows a trial and error process that should be applied to 
each lesion to get optimal visualization. However, because the overall number of 
projections is limited by time, safety and cost, the usual compromise is to obtain 
four to seven projections for the left and two to four for the right coronary artery. 
The resulting gap between adjacent projections, and thus the potential deviation 
from the optimal angle of observation, will range from 30° to >90° when only two 
projections are used. This gap can lead to serious underestimation of the severity 
of the stenosis and of its length. Besides being incomplete, this information 
entails considerable redundancy because each projection includes several 
cardiac cycles, yielding a series of highly intercorrelated images. From all these 
limitations, it appears clear that the conventional approach is not optimal.  
 
Rotational coronary angiography: 
 
To overcome these limitations, Tomassini et al in 1998, described a new 
approach that uses a dynamic rather than a fixed perspective, obtained by 
transverse 180° rotation of the C arm of a conventional angiographic unit, 
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accomplished manually in 4 seconds during standard selective coronary 
opacification and filming26. 
To evaluate the influence of foreshortening on the apparent length and severity 
of the stenosis they used a simple model of a concentric stenosis, based on a 
narrow tube (the stenosis) interposed between two larger tubes of equal radius 
(the normal segments) aligned on the same axis. This model and the 
corresponding silhouette from three different perspectives are depicted in Figure 
2. The correct perspective, which avoids foreshortening, is perpendicular to the 
axis of the tubes. Deviation from this perspective leads to progressive 
underestimation of the length and, above a certain threshold, of the severity of 
the stenosis. 
 
       
Figure 2. Model of concentric stenosis and the corresponding silhouette at different angles of 
observation.  
 
 
 
 12
The position of the patient was initially adjusted under fluoroscopy so that the 
heart lay approximately isocentric to the C arm. The image intensifier was 25° 
cranially or caudally tilted, then positioned 90° right lateral, close to the thoracic 
wall, and the C arm was manually rotated from the right to the left side during 
coronary injection and filming (Figure 3). 
 
                        
Figure 3. Schematic representation of a rotational scan. The image intensifier is positioned 90° 
right lateral with a fixed 25° cranial or caudal tilt. The C arm is then manually rotated to a -90° left 
lateral position in ~ 4 seconds. 
 
The potential for serious underestimation of the severity of stenosis was 
highlighted in this study as shown in Figure 4. 
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Figure 4. Severe ostial stenosis of the left main coronary artery seriously underestimated by the 
standard projections. Maximal stenosis (STEN) severity was 43% in a standard cranial 45° LAO 
projection (left) versus 70% in a rotational image approximately corresponding to a 20° cranial 
LAO projection (right).  
 
A complete diagnostic run for both coronary arteries, including two 25° cranial 
and two 25° caudal scans was accomplished with a total cine time of 16 sec and 
45 ml of contrast medium, about half of that required by conventional 
angiography. 
Hence, of 129 consecutive patients studied by both the conventional and the 
rotational technique with quantitative measurements of the severity of the 
stenoses, the final diagnosis was identical in 65. In no case was a stenosis 
detected only by the conventional approach. However, in 31 patients the new 
technique permitted identification of 34 critical stenoses (79 ± 8% [mean ± SD]) 
either underestimated (61 ± 3% n = 24, p < 0.001) or undetected (21 ± 22%, n = 
10, p < 0.001) in the standard projections. In a further 28 cases, 33 subcritical 
lesions (60 ± 5%) were visualized in the rotational images but were insignificant 
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(24 ± 22% p < 0.001) in the standard projections. In five additional patients, 
distinct laminar plaques were clearly visualized only by the panoramic approach. 
Rotational angiography offers the following advantages according to this study: 
1. Visualization of every lesion from all perspectives in the transverse plane in a 
single run, yielding maximal information with no redundancy. 
2. Panoramic representation of the coronary tree as a rotating image conveying 
complete three-dimensional information. This gives a better insight into the 
coronary tree and collateral circulation and permits a more accurate 
reconstruction of complex anatomies. 
3. Standardized, operator-independent approach. The panoramic technique does 
not rely on presumptive hypotheses on actual anatomy and does not involve an 
empirical choice of the most suitable projection to visualize a specific lesion. All 
information is obtained by two rotational scans with fixed 25° cranial and caudal 
angulation. Hence, this approach is standardized and basically operator 
independent, which is expected to improve reproducibility. 
4. Improved diagnostic accuracy. In this study, comparative analysis of the 
results was carried out by using the conventional classification of stenoses based 
on percent diameter reduction. The use of all transaxial projections allowed 
identification of a substantial number of critical stenoses which were either 
underestimated or undetected by the conventional technique. Also, several 
subcritical but significant (>50% and <70%) lesions were only detected by the 
new technique.  
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5. Use of less contrast medium and shorter cine runs. A complete rotational 
study comprises four scans, approximately 45 ml of contrast and 16 sec of cine, 
approximately half required by conventional coronary angiography. 
 
Kuon et al in 2002, demonstrated using a conventional image intensifier system 
that, compared with the standard techniques of coronary angiography, the 
method of rotational spin in invasive cardiology requires significantly less contrast 
medium: the 2 runs required for rotational coronary angiography necessitated 25 
± 4 ml consumption versus 64 ± 9 ml for complete documentation in standard 
mode27.  Overall radiation dose for the spin mode was slightly but not significantly 
higher than the overall standard mode. In this study, it was established that 
rotational spin enabled adequate image quality, comparable to standard mode. 
The proximal and mid segments as well as the periphery of the right coronary 
artery (RCA) achieved the best evaluation scores for cardiac spin, whereas the 
mid and proximal segments of the circumflex artery and the left anterior 
descending artery were judged slightly worse than for standard mode. The 
method of rotational cardiac spin was able to exactly document multiple left 
coronary artery (LCA) lesions and to reliably disclose lesions at crucial regions, 
such as the RCA ostium and bifurcations in circumflex and obtuse marginal 
arteries. 
In 2004, Maddux et al published a randomized study of the safety and clinical 
utility of rotational angiography versus standard angiography in the diagnosis of 
coronary artery disease28. This was the first randomized study to compare 
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prospectively, the safety and clinical utility of rotational coronary angiography to 
standard coronary angiography. Fifty-six patients undergoing coronary 
angiography were enrolled in this study. Twenty-eight patients were randomized 
to standard angiography and 28 patients were randomized to rotational 
angiography. A ceiling-mounted Philips Integris Allura 12” monoplane system 
was used. The standard angiography protocol consisted of four images of LCA 
using the traditional four gantry angles (LAO cranial, LAO caudal, RAO cranial, 
and RAO caudal views) and two different projections of the RCA (LAO, RAO, or 
AP cranial views). The specific gantry angles chosen and the magnification 
settings were per the operator’s discretion. The rotational angiography protocol 
consisted of three rolls or automated acquisition trajectories. Two 120° rotations 
(60° RAO to 60° LAO) were performed using both a 25° cranial and 25° caudal 
tilt during image acquisition of the LCA. A single 120° rotation (60° RAO to 60° 
LAO) with a 25° cranial orientation was performed during image acquisition of the 
RCA. Each 120° acquisition was completed in 4 sec. The primary endpoint of the 
study was patient safety (total contrast and radiation dose). The secondary 
endpoints of the study were operator safety (radiation exposure); time to 
complete a suitable angiographic study, and the clinical utility of rotational 
angiography using the number of additional image acquisitions needed above the 
protocol as an index of the adequacy or lack of adequacy of the rotational 
acquisition technique. Contrast utilization in the rotational angiography group was 
lower than in the standard angiography group (35.6 ± 12.6 vs. 52.8 ± 10.7 ml, 
respectively; p < 0.0001). This represents a 33% reduction in contrast use in 
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patients randomized to the rotational angiography group. Total radiation 
exposure was also markedly reduced in the rotational angiography group (37.2 ± 
13.2 vs. 53.9 ± 23.4 Gycm2, respectively; p < 0.002). This represents a 31% 
reduction in total radiation exposure in patients randomized to the rotational 
angiography group. Total whole-body radiation exposure or effective dose 
equivalent (EDE) to the primary operator was substantially lower in the rotational 
angiography group as compared to standard angiography (144 vs. 170 mrem, 
respectively). Patients randomized to the rotational angiography had a 41% 
reduction in the total number of image acquisitions needed to complete a 
diagnostic study (3.96 ± 1.17 vs. 6.75 ± 0.80 acquisitions, respectively; p < 
0.0001). The rotational protocol was completed in all patients with no crossover 
to standard angiography. One major advantage of rotational angiography over 
standard angiography is that it provided a large amount of information regarding 
the coronary tree with the use of less contrast and radiation. Using the rotational 
image acquisition protocol in this study, up to 360 projections from different 
angles of the coronary tree were obtained during a single angiographic study. 
During the standard angiographic protocol in this study, only six different 
projections of the coronary tree were obtained at the cost of higher contrast 
medium and radiation exposure to the patient. Furthermore, fluoroscopy radiation 
dose needed to isocenter the camera for image acquisition in the rotational 
angiography protocol was 66% lower than that required to center the camera for 
image acquisition during the standard angiography protocol. In accordance with 
the “as low as reasonably achievable” (ALARA) principle of the National Council 
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on Radiation Protection and Measurements (NCRP), the rotational angiography 
technique provides reduced patient radiation risk without the loss of the benefit of 
a complete angiographic study29.  There was no significant difference in the need 
for additional image acquisitions between the two groups. The need for additional 
angiographic images in the standard group may reflect the frequency of vessel 
overlap and foreshortening, which is not fully appreciated during standard 
angiography. The need for a second view of a coronary segment was more 
evenly distributed between the two groups; however, this response was seen 
more frequently in the rotational group. One explanation for this may be that 
more cranial or caudal orientation was needed in some patients during the set 
rotational protocol. In the rotational group, attending physicians felt that they 
needed to magnify on an area of interest to evaluate a coronary segment of 
interest. However, with flat detector imaging systems becoming widely available, 
the need for magnification does not require additional image acquisitions since 
digital magnification alone is sufficient.  The advantages and disadvantages of 
rotational versus standard coronary angiography as summarized in this study are 
as follows: 
 
Advantages 
 
1. Reduces radiation exposure to the patient and all personnel. 
2. Reduces contrast dose to the patient. 
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3. Provides additional perspectives of coronary artery tree, especially 
important for ostial, bifurcation, and very eccentric lesions. 
4. Produces a 3D visual effect helping operator’s assessment of branching 
patterns. 
5. Reduces the reliance on the operator’s skills to find optimal views. 
6. Allows standardization of images acquisition protocols. 
7. Images are internally calibrated to allow quantitative coronary angiography 
(QCA) without external calibration objects. 
 
Disadvantages 
 
1. No table panning during image acquisition is possible so that larger field of 
view may be needed to keep entire coronary tree in all images. 
2. Cannot be performed on older angiographic systems without rotational 
capabilities. 
3. Requires operator and staff to learn proper isocentering technique. 
4. Operator must learn to review angiographic runs with a constantly 
changing perspective. 
 
In 2005, Akhtar et al published a randomized study of the safety and clinical 
utility of rotational vs. standard coronary angiography using a flat-panel 
detector30. Their rotational system included three advances over prior studies: 
the use of a flat-panel imaging system; the height of the flat-panel detector was 
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lowered maximally to reduce the source-to-image distance; and the first 0.5 sec 
of each rotational angiogram included acquisition with a fixed gantry position to 
allow ascertainment of coronary calcification prior to injection of contrast as well 
as coronary velocity with the initiation of contrast injection. They hypothesized 
that the use of rotational angiography would reduce contrast utilization and X-ray 
exposure while achieving the same level of diagnostic accuracy. All angiographic 
procedures were performed from the femoral arterial approach using a ceiling-
mounted flat-panel detector monoplane system with a rotational angiographic 
software package (Allura Xper FD 10, Philips Medical Systems, Bothell, WA). 
Hand injection of up to 10 ml of contrast was used for selective coronary 
angiography. Two 100º rotations (RAO 50º to LAO 50º) with either a 25º cranial 
or 30º caudal tilt were performed for LCA acquisition. A single 100º rotation (RAO 
50º to LAO 50º) with 25º cranial tilt was performed for RCA acquisition. Contrast 
utilization in the rotational angiography group was 40% lower as compared to the 
standard angiography group (24 ± 5 vs. 40 ± 10 ml, respectively; P < 0.0001). 
Radiation exposure and fluoroscopy time was not significantly different between 
the rotational or standard angiography groups. There was no significant 
difference in the need for additional image acquisitions beyond the protocol 
acquisitions in the rotational and standard angiography groups. To assess the 
impact of the learning curve for rotational angiography, subgroup analysis was 
performed comparing early (n = 13) vs. late (n = 12) studies within each study 
arm. In the rotational angiography arm, early studies tended to utilize more time 
for coronary acquisition. Early studies also used more fluoroscopy time 
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compared to late studies. In addition, all cases requiring additional image 
acquisitions in the rotational arm occurred during the early phase. 
In 2007, Garcia et al published an initial clinical experience of selective coronary 
angiography using one prolonged injection and a 180º rotational trajectory31. This 
study demonstrated the feasibility and safety of longer coronary injections of 7.2 
sec. There were no significant HR changes, clinically insignificant pressure 
changes, and no adverse reactions. A newer application of rotational 
angiography which is undergoing research is 3 D reconstruction of coronary 
models from angiogram images as shown in Figure 5.   
 
        
        Figure 5. 3 D model obtained from rotational angiogram images 
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In 2009, Garcia et al published a study70 that compared the image content of 
rotational angiography with standard angiography. This study showed that 
rotational angiography provides a similar if not superior image analysis capability 
when compared to standard angiography. Quantitative and qualitative lesion 
assessment is a pivotal part of coronary angiography. Rotational angiography 
has the power to detect a similar or higher amount of lesions when directly 
compared to standard angiography. Moreover it is comparable to standard 
angiography in evaluating lesion severity and ACC lesion type. The screening 
adequacy of rotational angiography has also been evaluated. The study shows 
that when comparing both imaging modalities side by side and evaluating all 
vessel segments and calcification, there is no significant difference between 
them.  
Some differences however are worth mentioning. Standard angiography seems 
to be superior in the evaluation of TIMI flow and collaterals. Because the 
rotational run usually begins right before the acquisition begins it becomes 
difficult to evaluate TIMI flow. However, newer rotational acquisition protocols 
include an initial delay in the run (0.5 sec) so that TIMI flow can be evaluated. 
With the inclusion of this feature there would be no difference between rotational 
angiography and standard angiography in the evaluation of TIMI flow and 
probably on vessel collateralization. On the other hand rotational angiography 
seems to be superior to standard angiography in the visualization of several 
coronary artery segments (first diagonal, distal RCA, postero-lateral branches, 
and the posterior-descending artery). In addition it seems to deliver a better 
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survey of the different coronary ostiums although this was not rigorously 
evaluated. In this study, rotational angiography had a 40% reduction on contrast 
exposure and a 15% reduction in radiation exposure when compared to standard 
angiography.  
 
Definitions: 
Exposure is the radiation level at a point in space, commonly measured with an 
ionization chamber in units of air kerma (kinetic energy released in material; dose 
delivered to air). 
Dose refers to the local concentration of energy absorbed by tissue from the x-
ray beam when the exposure interacts with the individual atoms in the tissue. 
Dose area product (DAP) is the product of the air dose at a certain distance 
from the x-ray tube and the cross sectional area of the x-ray beam at the same 
distance. The unit is the gray cm2. DAP is actually independent of distance; as 
distance increases, air dose decreases and beam size increases in an exactly 
offsetting manner. Because most of the x-ray beam is absorbed by the patient, 
DAP is a conveniently measurable surrogate for effective dose. Most currently 
used interventional fluoroscopes include a DAP meter. DAP includes both fluoro 
and cine exposure and reflects the influence of tissue thickness on skin dose. But 
because the same DAP can be delivered as either a high dose to a small field 
size or as a low dose to a large field size, it cannot be used directly to predict the 
possibility of a skin injury (which would be significantly higher in the former case). 
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Flat-Panel X-Ray Detectors 
 
The image intensifier/video camera combination is currently being displaced by 
integrated digital image receptors (flat-panel detectors). The imaging behavior of 
a flat-panel system differs from an image intensifier/digital video system in one 
important respect. As shown in Figure 6, when an image intensifier is zoomed, 
less and less of the patient is imaged by the tube's fixed-size output screen. 
Therefore each pixel in the zoomed image is smaller (relative to the patient) than 
for the unzoomed case; i.e., spatial resolution increases with zoom. In the flat-
panel case, zooming simply uses fewer of the available pixels, so that the 
intrinsic spatial resolution does not increase with zoom. However, the digitally 
magnified image on the monitor may provide better detail coupling to the 
observer's eye, increasing the clinically effective resolution as a flat-panel system 
is zoomed32. Figure 7 shows a Philips Allura XP FD10 Flat-Panel Detector. 
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Figure 6. Zoom differences between image intensifiers and flat-panel detectors. The image before 
digitization (A); full-field digitization for both systems - typically a matrix size of 1,024 x 1,024 (B). 
When the image intensifier is zoomed (C), the same matrix covers a smaller field of view; this 
reduces the effective pixel size. When a first-generation flat-panel is zoomed (D), the pixel size 
remains the same; fewer pixels are used. Displays are usually electronically zoomed to fill the 
monitor. This does not increase physical resolution, but may improve the visibility of detail. 
 
                          
                         Figure 7. Philips Allura XP FD10 (Flat-Panel Detector) 
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Biologic effects of radiation: 
 
Stochastic Effects 
The word stochastic is defined as involving chance or probability. Stochastic 
effects are presumably induced by a single photon causing unrepaired injury to 
the DNA of a single viable cell. Depending on their type, damaged cells can 
proliferate to produce a malignancy in the irradiated individual or a genetic 
disorder in future generations. The severity of the resultant injury, caused by 
propagation of a single (unrepaired) damaged cell, is independent of the dose 
that started the process33, 34.  Because manifestation of the injury requires 
cellular propagation, stochastic effects are typically seen years to decades after 
irradiation. Radiation-induced leukemia thus occurs between 2 and 25 years after 
irradiation, whereas solid radiogenic cancers have a latent period of 5 to 20 
years. 
 
Deterministic Effects 
Deterministic effects occur when a significant number of existing cells are 
sufficiently damaged so as to cause observable injury. Immediate injury is either 
owing to massive cell killing or a prompt biochemical tissue response to radiation. 
Delayed injuries become manifest when injured cells die without being replaced. 
The threshold dose for a deterministic effect depends on the fraction of cells that 
need to be killed before tissue loses viability, whereas the time course is 
dependent on the nature of the tissue and its cellular kinetics. 
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As of 2005, new imaging systems for the catheterization laboratory are required 
to record not only fluoroscopy time but also DAP or Kerma Area Product (KAP) 35, 
36. DAP/KAP is a more accurate assessment of skin dose than fluoroscopy time 
by accounting for both cine acquisition and fluoroscopy; it is the standard for 
assessing post procedure skin injury37. These deterministic effects of radiation 
toxicity begin with early transient erythema at 2 Gy and progress to ischemic 
dermal necrosis at 18 Gy36. The stochastic effects reflecting cancer risk have no 
definable threshold.  
 
Contrast induced nephropathy: 
 
The reported incidence of contrast-induced acute kidney injury (AKI) varies 
widely across the literature, depending on the patient population and the baseline 
risk factors. The most commonly used definition in clinical trials is a rise in serum 
creatinine (SCr) of 0.5 mg/dl or a 25% increase from the baseline value, 
assessed at 48 hours after the procedure. It has been recognized for some time 
that the risk of death is increased in patients developing contrast-induced AKI38-
42.  
In a large retrospective study of over 16,000 hospitalized patients undergoing 
procedures requiring iodinated contrast, patients with contrast-induced AKI had a 
5.5-fold increased risk of death43. In contemporary studies, contrast-induced AKI 
requiring dialysis developed in almost 4% of patients with underlying renal 
impairment44. 
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Chronic kidney disease (CKD) is identified by an estimated glomerular filtration 
rate (eGFR) < 60 ml/min/1.73 m2. Almost every multivariate analysis has shown 
that CKD is an independent risk predictor for contrast-induced AKI44-49. Since SCr 
alone does not provide a reliable measure of renal function, the National Kidney 
Foundation Kidney Disease Outcome Quality Initiative recommends that 
clinicians should use an eGFR calculated from the SCr as an index of renal 
function rather than using SCr50 in stable patients. The risk of contrast-induced 
AKI is increased in patients with an eGFR < 60 ml/min/1.73 m2, and special 
precautions should be taken in these patients51. Other risk markers include 
diabetes mellitus (DM) 52, 53, volume depletion54, nephrotoxic drugs, 
hemodynamic instability55, 56, and other comorbidities. Anemia has also been 
reported as a predictor of contrast-induced AKI57. However, the concept is that in 
a patient with CKD, DM, and other comorbidities, predicted risks of contrast-
induced AKI and emergency dialysis can approach ~ 50% and ~ 15%, 
respectively. Iodixanol has been shown to have the lowest risk for contrast-
induced AKI in patients with CKD and DM58, 59. 
 
Volume of contrast - Numerous studies have shown that the volume of contrast 
medium is a risk factor for contrast induced AKI. The mean contrast volume is 
higher in patients with contrast-induced AKI, and most multivariate analyses have 
shown that contrast volume is an independent predictor of contrast-induced 
AKI48, 52, 56, 60. However, even small volumes (~ 30 ml) of contrast medium can 
have adverse effects on renal function in patients at particularly high risk61. As a 
 29
general rule, the volume of contrast received should not exceed twice the 
baseline level of eGFR in milliliters62. This means for patients with significant 
CKD, a diagnostic catheterization should plan to use ~ 30 ml of contrast, and if 
followed by PCI then ~ 100 ml should be a reasonable goal. Volume expansion 
and treatment of dehydration has a well-established role in prevention of 
contrast-induced AKI, although few studies address this theme directly. There 
are limited data on the most appropriate choice of intravenous fluid, but the 
evidence indicates that isotonic crystalloid (saline or bicarbonate solution) is 
probably more effective than half-normal saline63. Although popular, N-Acetyl 
Cysteine (NAC) has not been consistently shown to be effective. Importantly, 
only in those trials where NAC reduced SCr below baseline values because of 
decreased skeletal muscle production did renal injury rates appear to be 
reduced. Thus, NAC appears to falsely lower Cr and not fundamentally protect 
against AKI. However, NAC as an antioxidant has been shown to lower rates of 
AKI and mortality after primary PCI in 1 trial64. The recently published REMEDIAL 
(Renal Insufficiency Following Contrast Media Administration) trial suggested that 
the use of volume supplementation with sodium bicarbonate together with NAC 
was more effective than NAC alone in reducing the risk of AKI65. 
In adults the best equation for estimating glomerular filtration rate (GFR) from 
serum creatinine is the Modification of Diet in Renal Disease (MDRD) Study 
equation66.  
GFR (mL/min/1.73 m2) = 186 x (Scr)-1.154 x (Age)-0.203 x (0.742 if female) x       
(1.212 if African-American)  
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METHODOLOGY 
 
The study was performed among consecutive patients undergoing coronary 
angiography at the Cardiology Department of Christian Medical College, Vellore; 
a tertiary care institute in South India. This study was approved by the 
Institutional Review Board (IRB).  
 
Inclusion criteria:  
Patients undergoing coronary angiography, including those with renal dysfunction 
and/or LV dysfunction. 
Renal dysfunction is defined as GFR < 60ml/min/1.73m2 
LV dysfunction is defined as LVEF < 50% 
 
Exclusion criteria:  
• Known allergy to iodinated contrast 
• Acute coronary syndrome 
• Decompensated heart failure 
• Prior coronary-artery bypass- graft (CABG)   
• Pregnancy 
 
Rotational coronary angiography:  
Patient baseline demographics, including serum creatinine and LVEF were noted 
prior to the procedure. 
 All angiographic procedures were performed after written, informed consent, 
from the femoral arterial approach using a ceiling-mounted flat-panel detector 
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monoplane system with a rotational angiographic software package (Allura Xper 
FD 10, Philips Medical Systems). Coronary angiography was performed with a 
standard catheter set including Judkins Left and Judkins Right catheters.  
Controlled hand injections were used for selective coronary angiography. All 
procedures were performed by a single operator, who was a cardiology trainee. 
Iohexol (Omnipaque) was the contrast used for most of the patients. Iodixanol 
(Visipaque) was used when the serum creatinine was > 1.3 mg/dl. Patients with 
serum creatinine > 1.3 mg/dl prior to the procedure received saline hydration and 
NAC. Patients assigned to rotational angiography had a total of three coronary 
acquisitions specified by the protocol. Prior to acquisition, the patient’s heart was 
isocentered using fluoroscopy in the anteroposterior and left lateral positions. 
Once contrast injection was initiated, the cine pedal was pressed and high-speed 
rotation of the gantry was initiated in a predefined trajectory. Initiation of the 
rotation was started immediately after contrast was noted to fill the entire 
coronary. During spin acquisition, the gantry moved through an arc at a rate of 
27.5°/sec. Two 110º rotations (RAO 55º to LAO 55º) with a 25º cranial and 25º 
caudal tilt were performed for LCA acquisition. A single 110º rotation (RAO 55º to 
LAO 55º) was performed for RCA acquisition. Each rotational acquisition was 
completed in 4 sec and 121 frames. All cine angiograms were recorded at 15 
frames/sec. Additional coronary acquisitions were taken when required at the 
discretion of the operator and a consultant cardiologist. 
Fuoroscopy time was recorded from the time of arterial sheath insertion till the 
completion of coronary angiography. Two other measures of radiation dose [dose 
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area product (DAP, Gycm2) and air kerma (Gy)] for fluoroscopy and image 
acquisition were recorded from the Philips Allura Xper system. 
Coronary contrast media utilization used to acquire the protocol and any 
additional coronary angiographic images was recorded. 
The patient was hemodynamically monitored during the procedure and was 
watched for any adverse event including contrast allergy. 
Assessment of images was done by the primary operator and a consultant 
cardiologist, which was in terms of image quality and adequacy of anatomic 
information provided for further management.  
Serum creatinine was checked and recorded 48 hours after coronary angiogram.  
 
Statistical analysis:  
Data was presented using percentages and means with standard deviation. The 
comparison of contrast volume used and radiation dose in rotational angiography 
and standard angiography was assessed using students t test and confidence 
intervals for the same were constructed. Pre and post angiogram renal function 
was tested for statistical significance using the paired t test. Pearson’s correlation 
coefficient was used to analyze the correlation between BMI and radiation dose 
and fluoroscopy time and radiation dose. Results were considered statistically 
significant at p < 0.05. The statistical analysis was performed using Microsoft 
Excel 2003 and SPSS for Windows (15.0). 
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RESULTS 
 
A total of 64 patients were studied. Table 1 shows the demographic 
characteristics of the patients studied. 
 
The mean age of the subjects was 55.42 ± 7.54 years; they were predominantly 
males (79.7%).  There were 27 (42.2%) diabetics and 33 (51.6%) were 
hypertensive. The mean BMI was 23.76 ± 3.98 kg/m2. The mean  cardiothoracic 
ratio (CTR) was 50.73 ± 6.58 %. There were 2 patients (3.1%) who had end-
stage renal disease and were on hemodialysis. The mean serum creatinine was 
1.20 ± 0.91 mg/dl and the mean GFR was 75.01 ± 18.92 ml/min/1.73m2. The 
mean LVEF was 50.38 ± 8.85 %.   Twenty three patients (43.8%) had normal 
coronaries and 8 (12.5%), 9 (14.1%), 7 (10.9%), 8 (12.5%) had single, double 
and triple vessel coronary artery disease respectively.  One patient (1.6%) had 
left main with double vessel disease and 3 patients (4.7%) had left main with 
triple vessel disease. Thirty one patients underwent renal angiography out of 
which 27 (87%) had normal renal arteries, 2 (6.4%) each had minor and 
significant renal artery disease respectively. 
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Table 1. Demographic characteristics (numbers in brackets indicate 
percentages) 
 
Mean age (years) ± SD 55.42 ± 7.54 
Male sex  51 (79.7) 
Mean height (cms) ± SD 163.34 ± 7.60 
Mean weight (kg) ± SD 62.83 ± 10.19 
Mean BMI (kg/m2) ± SD 23.76 ± 3.98 
Mean CTR (%) ± SD 50.73 ± 6.58 
Renal disease     2 (3.1) 
Diabetes Mellitus  27 (42.2) 
Hypertension  33 (51.6) 
Smoking  21 (32.8) 
Dyslipidemia  12 (18.8) 
Previous ACS  19 (29.7)  
Mean serum creatinine (mg/dl) ± SD 1.20 ± 0.91 
Mean GFR (ml/min/1.73sq.m.) ± SD  75.01 ± 18.92 
Mean LVEF (%) ± SD 50.38 ± 8.85 
Coronary angiogram (n = 64) 
Normal 
Minor 
SVD 
DVD 
TVD 
LDVD 
LTVD 
 
 
28 (43.8) 
  8 (12.5) 
  9 (14.1) 
  7 (10.9) 
  8 (12.5) 
  1 (1.6) 
  3 (4.7) 
Renal Angiogram (n = 31) 
Normal 
Minor 
RAS 
 
27 (87) 
 2 (6.4) 
 2 (6.4) 
 
SD = Standard Deviation, BMI = Body Mass Index, CTR = Cardio Thoracic Ratio, 
ACS = Acute Coronary Syndrome, GFR = Glomerular Filtration Rate, SVD = 
Single Vessel Disease, DVD = Double Vessel Disease, TVD = Triple Vessel 
Disease, LDVD = Left main with Double Vessel Disease, LTVD = Left main with 
Triple Vessel Disease, RAS = Renal Artery Stenosis. 
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The mean total contrast volume used for rotational coronary angiography in this 
study was 22.44 ± 5.16 ml (n = 64). The mean contrast volume used for LCA and 
RCA was 15.03 ± 2.17 ml and 4.95 ± 0.82 ml respectively. This was compared 
with the mean total contrast volume used for standard coronary angiography 
obtained from unpublished data in Christian Medical College, Vellore which was 
38.16 ± 7.7 ml (n = 25). The mean contrast volume used for LCA and RCA was 
26.96 ± 5.7 ml and 11.2 ± 3.25 ml respectively. 
 
Figure 1. Comparison of contrast volume used for standard versus 
rotational angiography 
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LCA = Left Coronary Artery, RCA = Right Coronary Artery 
 
 
 
p < 0.05 
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Table 2. Contrast Volume used for standard coronary angiography and 
rotational angiography 
 
 Standard Rotational P value 95% CI 
    
 
Lower Upper 
LCA  (ml) 26.96 ± 5.7 15.03 ± 2.17 < 0.05 9.63 14.22 
RCA  (ml)  11.2 ± 3.25 4.95 ± 0.82 < 0.05 4.96 7.53 
Total 
Volume (ml) 
38.16 ± 7.7 22.44 ± 5.16 < 0.05 12.48 19.03 
 
 
There was a statistically significant reduction in contrast volume used in 
rotational angiography as compared to standard angiography. 
 
Figure 2. Comparison of radiation dose for standard versus rotational 
angiography 
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DAP = Dose Area Product, SD = Standard Deviation  
p < 0.0001 
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The mean DAP in this study was 20.64 ± 7.18 Gycm2. This was compared with 
data for standard angiography which was obtained from previously published 
data from Christian Medical College, Vellore67. The radiation dose for standard 
angiography was 55.86 ± 5.75 Gycm2. The difference was statistically significant 
(p < 0.0001). The 95 % CI of this estimate was 32.36 – 38.07.  
 
Figure 3. DAP Values According to BMI 
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DAP = Dose Area Product, BMI = Body Mass Index 
 
The average DAP was 18.5 ± 5.49, 23.44 ± 7.66, 30.01 ± 9.29 Gycm2 for patients 
with BMI < 25, 25-30 and > 30 kg/ m2 respectively. Figure 3 shows graphically 
that there was a trend to higher DAP values for patients with a higher BMI. Figure 
4 shows a positive correlation in the scatter plot where r2 = 0.34. This correlation 
n = 43 n = 16 n = 6
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was found to be significant (p < 0.0001) on analysis using Pearson’s correlation 
coefficient. 
 
Figure 4. Scatter plot showing the relation between DAP (Gycm2) and BMI 
(kg/m2) 
 
 
Table 3.  Pearson’s correlation coefficient statistics 
 
 
 
Modality Mean 
 
Standard 
deviation
Pearson’s 
correlation 
coefficient with DAP 
 
 
Significance  
(2 tailed) 
 
 
BMI (kg/m2) 
 
23.76 
 
3.97 
 
 
0.579 
 
 
< 0.0001 
 
Fluoroscopy 
time (min) 
1.65 0.77 0.461 < 0.0001 
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Figure 5. Scatter plot showing the relation between DAP (Gycm2) and 
Fluoroscopy time (min) 
 
Figure 5 shows a positive correlation between DAP and fluoroscopy time in the 
scatter plot where r2 = 0.21.  However, DAP had a stronger correlation with BMI 
than fluoroscopy time. 
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Figure 6. Comparison of fluoroscopy time in first and second halves of the 
study 
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Patients who underwent rotational angiography (n = 64) were divided into two 
groups. The first 32 patients were included in the ‘first half’ group and the 
remaining patients were included in the ‘second half’ group. The mean 
fluoroscopy time in the ‘first half’ group was 2.07 ± 0.65 min as compared to 1.22 
± 0.64 min in the ‘second half’ group. The difference in the mean fluoroscopy 
time of the two groups was statistically significant (p < 0.05).  
Hence, there is a definite learning curve involved in rotational angiography. 
Figure 7 graphically depicts the gradual reduction in fluoroscopy time with case 
numbers.  
 
 
p < 0.05 
n = 32 n = 32 
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Figure 7. Learning curve for rotational angiography 
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 A sub group analysis was done on patients with compromised renal function and 
reduced LVEF prior to the procedure.  
There were a total of 8 (12.5%) patients with pre-procedural GFR < 60 
ml/min/1.73m2. Two (3.1%) of these patients had end-stage renal disease and 
were on maintenance hemodialysis. Hence, no post-angiography serum 
creatinine was done for these patients. Table 3 shows the pre-angiography and 
post-angiography GFR. None of the 6 patients had worsening of GFR post 
angiography. Figure 8 shows graphically that there was no worsening of GFR 
after rotational angiography in patients with a baseline GFR of < 60 
ml/min/1.73m2. The difference in GFR, pre and post-angiography was not 
significant (p = 0.116). 
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Table 3. Comparison of pre-angiography and post-angiography GFR in 
patients with baseline GFR < 60 ml/min/1.73m2 
 
S.No Pre-angiography Post-angiography 
1 9.17 NA 
2 12.11 NA 
3 43.83 43.83 
4 54.58 80.47 
5 55.32 66.09 
6 57.49 68.68 
7 59.65 59.65 
8 59.71 59.71 
 
Figure 8. Comparison of pre-angiography and post-angiography GFR in 
patients with baseline GFR < 60 ml/min/1.73m2 
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Paired Samples Test 
 
 
  Mean 
Std. 
Deviation
Std. 
Error 
Mean 
95% Confidence 
Interval of the 
Difference t 
 
 
 
Df
Sig.  
 
(2-
tailed) 
Pair 
1 
GFR1
-
GFR2 
 
 
-7.9750 10.29463 4.20277
Lower 
 
-18.77855 
Upper 
 
2.82855 -1.89 5 .116
 
 
The other subgroup was that of patients with an LVEF < 50%. There were 22 
patients with LV dysfunction. The mean LVEF was 39.27 ± 5.68 %. In these 
patients the pre-angiography and post-angiography GFR was compared. Table 4 
shows a comparison of pre-angiography and post-angiography GFR in patients 
with baseline LVEF < 50%.  
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Table 4. Comparison of pre-angiography and post-angiography GFR in 
patients with baseline LVEF < 50% 
 
S.No Pre-angiography Post-angiography 
1 54.58 80.47 
2 55.32 66.09 
3 60.96 41.34 
4 61.38 61.38 
5 62.90 56.35 
6 64.88 64.58 
7  65.21 65.21 
8 65.87 65.87 
9 68.40 57.25 
10 70.75 70.75 
11 70.98 64.66 
12 72.09 72.09 
13 72.57 72.57 
14 76.60 63.17 
15 81.57 81.57 
16 83.40 83.40 
17 91.49 91.49 
18 93.12 93.12 
19 94.18 94.18 
20 98.01 84.01 
21 102.06 90.38 
22 110.13 110.13 
 
 
The difference in GFR, pre and post-angiography was not significant (p= 0.30). 
 
 
 
Paired Samples Test 
 
 
  Mean 
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Deviatio
n 
Std. 
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Mean 
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Sig. 
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1 - 
GFR 
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1.97091
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-2.00372
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.300 
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No patients in the study developed contrast induced nephropathy.  
However, 9 (14 %) patients had a GFR < 60 ml/min/1.73m2  post-angiography. 
The mean age of this group of patients was 56 ± 6.0 years and 5 (55.6%) were 
males. Five (55.6%) of these patients were diabetics. 
The pre-angiography and post-angiography GFR is tabulated in Table 5 and the 
paired t test showed the difference to be significant (p = 0.031).  
 
Table 5. Comparison of pre-angiography and post-angiography GFR in 
patients with post-angiography GFR < 60 ml/min/1.73m2 
 
 
S.No Pre-angiography Post-angiography 
1 60.96 41.34 
2 43.83 43.83 
3 66.33 55.52 
4 62.90 56.35 
5 68.40 57.25 
6 57.25 57.25 
7  59.65 59.65 
8 59.71 59.71 
9 65.60 59.85 
 
  
 
 
Paired Samples Test 
 
 
  Mean 
Std. 
Deviation
Std. Error 
Mean 
95% Confidence 
Interval of the 
Difference t df 
Sig. 
(2-
tailed)
Pair 
1 
GFR 
1 - 
GFR 
2 
 
 
 
5.98667 
 
 
 
6.88773 
 
 
 
2.29591 
Lower 
 
 
.69229 
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11.28104 
 
 
 
2.608 
 
 
 
8 
 
 
 
.031 
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Figure 9. Rotational angiogram images of LCA injection. Images are seen from 
RAO caudal to LAO caudal showing a proximally occluded LAD. The distal LAD 
is seen filling from left to left collaterals. 
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Figure 10. Rotational angiogram images of RCA injection. Images are seen from 
RAO caudal to LAO caudal showing a normal dominant RCA. 
 
Image quality was good in all cases. Additional views were taken in 15 patients 
with significant coronary artery disease but these did not provide any additional 
information for assessment of lesion severity (% stenosis) and further 
management. Of the 64 angiographies done, 43.8% had normal coronaries. 
12.5%, 14.1%, 10.9%, 12.5%, 1.6% and 4.7% had minor, single, double, triple, 
left main with double and left main with triple vessel disease respectively. Of 
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these patients 65.6% were advised medical management. 18.8% and 15.6% 
were advised coronary angioplasty and coronary bypass graft surgery 
respectively. 
No patients had any adverse effects and there was no mortality. 
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DISCUSSION 
 
In the present study, we have tested the feasibility of performing rotational 
angiography in routine practice, in a busy cardiac catheterization laboratory 
setting. Though it is a relatively new technique, it could be learnt and applied 
effectively in terms of being able to perform it routinely on a day to day basis. 
 
The mean total contrast volume used for rotational coronary angiography in this 
study was 22.44 ± 5.16 ml. This was significantly less than that used for standard 
coronary angiography, according to data obtained from unpublished data in 
Christian Medical College, Vellore which was 38.16 ± 7.7 ml. Our findings 
confirm prior reports that rotational coronary angiography reduces patient 
exposure to contrast medium. The magnitude of reduction in contrast exposure 
by 41.19% in our study was similar to the reduction reported by Akhtar et al in 
2005, who had used a Flat-Panel detector similar to that used in our study (40%) 
30.  
Maddux et al. in 2004 had reported a 33% reduction in contrast volume using an 
older imaging system for rotational angiography28. Kuon et al. previously noted a 
61% reduction in contrast exposure by rotational angiography. However, this 
finding may be an overestimate given their older imaging technology and small 
sample size (n = 15) 27.  
The radiation dose during rotational angiography in our study was 20.64 ± 7.18 
Gycm2. This was much lower (41 - 47%) as compared to prior studies. Maddux et 
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al. reported a mean radiation dose of 39 ± 19 Gycm2 for rotational coronary 
angiography with the image intensifier Philips system28. Akhtar et al reported that 
the average radiation dose was 35 ± 14 Gycm2 for rotational coronary 
angiography with the Philips Allura Xper FD 10 flat-panel detector30. The 
radiation dose for rotational angiography in this study was also found to be 
significantly less as compared with data for standard angiography which was 
obtained from previously published data from Christian Medical College, 
Vellore67. The radiation dose for standard angiography in this study was 55.86 ± 
5.75 Gycm2.  This reduction in radiation dose with rotational angiography was 
comparable to other studies28, 30. 
There was a positive correlation between DAP and fluoroscopy time.  However, 
DAP had a stronger correlation with BMI than fluoroscopy time.  The relationship 
between patient weight and radiation dose has been established previously in 
invasive cardiologic studies. Ector et al. in 2007 found a significant correlation 
between patient radiation dose and BMI comparable to that found in our study68.  
Their study evaluated the impact of obesity on patient radiation dose during atrial 
fibrillation (AF) ablation procedures under fluoroscopic guidance. They concluded 
that there was a stronger correlation of DAP with BMI than with fluoroscopy time. 
However, this may be clinically more relevant in case of long procedures rather 
than short procedures like coronary angiography. 
There is a definite learning curve involved in rotational angiography as was 
demonstrated by a significant decrease in fluoroscopy times with case numbers. 
This has been described in earlier studies on rotational coronary angiography by 
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Raman et al in 200469 and Akhtar et al in 200530. The fluoroscopy times in these 
studies were timed from selective catheter engagement in each coronary ostium. 
However, in our study, fluoroscopy time was timed from the time of femoral 
arterial sheath insertion to the end on the angiography. Hence the fluoroscopy 
times are not comparable with earlier studies.  
A sub group analysis was done on patients with compromised renal function and 
poor LVEF prior to the procedure. None of these patients had worsening of GFR 
post angiography. No patients in the study developed contrast induced 
nephropathy. This is probably due to the low contrast volume (22.44 ± 5.16 ml) 
used for rotational coronary angiography. Numerous studies have shown that the 
volume of contrast medium is a risk factor for contrast induced AKI. The mean 
contrast volume is higher in patients with contrast-induced AKI, and most 
multivariate analyses have shown that contrast volume is an independent 
predictor of contrast-induced AKI48, 52, 56, 60.  
However, 9 (14 %) patients had a GFR < 60 ml/min/1.73m2 post-angiogram. 
Five (55.6%) of these patients were diabetics. None of these patients had a rise 
in serum creatinine > 0.5mg/dl or > 25% of baseline serum creatinine at 48 hours 
after angiography. So, by definition, none of them had contrast induced 
nephropathy. However there was a significant difference between pre-angiogram 
and post-angiogram GFR. The mean pre-procedure GFR in these patients was 
60.51 ± 7.22 ml/min/1.73m2 and baseline serum creatinine was < 1.3 mg/dl. 
Hence these patients were not given saline hydration or NAC according to 
protocol.  This could explain the worsening of GFR in these patients with a 
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‘borderline GFR’ most of who were diabetics at high risk for developing contrast 
induced nephropathy. Hence, it is likely that many such patients may be 
developing transient asymptomatic worsening of GFR which may go undetected 
since monitoring of serum creatinine is not a routine practice after coronary 
angiography in patients with normal serum creatinine prior to angiography.  
There are no studies so far which have evaluated the long term impact of this on 
renal function.  Therefore estimation of GFR prior to use of radiocontrast may be 
a better way to assess actual renal function and risk for contrast induced 
nephropathy rather than serum creatinine which may be normal and hence 
misleading in many cases. 
Even small volumes (~ 30 ml) of contrast medium can have adverse effects on 
renal function in patients at particularly high risk61. This could also explain the 
worsening of GFR in patients with a pre-procedural borderline GFR in our study. 
As a general rule, the volume of contrast received should not exceed twice the 
baseline level of eGFR in milliliters62.  
Though no definite parameters to assess image adequacy70 were used in this 
study, assessment of coronary angiograms was done in terms of image quality 
and adequacy of anatomic information obtained, by the primary operator and a 
consultant cardiologist. Image quality was good in all cases. Additional views 
were taken in 15 patients with significant coronary artery disease but these did 
not provide any additional information for assessment of lesion severity (% 
stenosis) and further management. The information obtained by rotational 
coronary angiography was sufficient to plan management in all cases. 
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Thus rotational coronary angiography is a new technique which offers a 
significant reduction in contrast volume and radiation dose. Though easy to 
perform, there is a definite learning curve involved. Rotational angiography 
provides image quality which is comparable to standard angiography and in 
some cases even better, by means of providing a panoramic view of the entire 
coronary tree which is independent of the operator’s ability to find the best view 
to visualize a part of a particular coronary artery. It appears to have a definite role 
in patients at risk for developing contrast induced nephropathy, by significantly 
limiting contrast volume.  Rotational coronary angiography may also be of use in 
low risk patients, pre-renal transplant recipients and pre-valve surgery patients 
where it significantly saves precious time in a busy cath lab by means of reducing 
fluoroscopy and procedure times. By means of decreased dependence on the 
operator to find the optimal view, coupled with low risk patients, this procedure 
can be safely done by cardiology trainees in this group of patients, leaving senior 
cardiologists to focus on more complex procedures. 
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LIMITATIONS 
 
1. Damping of pressures was noted in many patients after catheter 
engagement of the RCA ostium. Positioning and isocentering usually 
takes atleast 30 seconds but required to be hastened due to damping.  
This theoretically exposes the patient to a risk of bradycardia or ventricular 
arrhythmias on injection of contrast. However, none of the patients 
experienced any such complications in this study and no procedure was 
aborted due to this. 
2. Fifteen patients had damping of pressures after RCA catheter 
engagement and did not have reflux of contrast. Hence, additional views 
were required to demonstrate reflux, ostial spasm and relief of the same 
with nitroglycerin. 
3. The time taken for the rotational arc is a minimum of 4 seconds excluding 
the time for positioning and isocentering, which in real practice may take 
30 seconds to 1 minute, depending on the experience and expertise of the 
technical staff. Hence a stable catheter position is of paramount 
importance without which the whole process of engaging, positioning and 
isocentering would have to be repeated. This would mean an additional 
expense of time, radiation and contrast. 
4. Incase of a deep catheter engagement especially with the RCA, a careful 
pull-back of the catheter during rotational angiography may not be 
possible as there is a risk of catheter disengagement and having to repeat 
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the process afresh. Pull-back of the catheter to visualize ostial lesions also 
carries the same risk.   
5. Though rotational angiography is feasible in obese patients and in patients 
with cardiomegaly as demonstrated in this study, it does require much 
more careful positioning and isocentering since panning the table as is 
possible with standard angiography is not an option. For the same reason, 
rotational angiography may pose difficulties in patients with abnormal 
positions of the heart. 
6. Visualization of collaterals usually requires prolonged injection of contrast. 
Since the rotational arc lasts only 4 seconds, there were few patients with 
chronic occlusions in whom collaterals could not be clearly visualized. 
Also, the collaterals arising from contralateral vessels may not be captured 
in the field of the angiogram. This means that these patients would require 
additional views to visualize collaterals. 
7. This procedure involves a learning curve for both the operator and 
assistants especially with regard to the isocentering and injection 
technique. Improper isocentering would cause segments of a vessel not 
being visualized. Failure to start injection just prior to cineangiography 
would cause the rotational arc to start before opacification of the coronary 
arteries and hence non-visualization of the coronaries for the initial few 
frames. Too rapid hand injection would cause depletion of contrast before 
the rotational arc is completed and the latter frames would not be 
opacified.  
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SUMMARY OF MAIN FINDINGS 
 
 
 
1. Rotational coronary angiography is a practically feasible and easy 
technique which can be routinely performed in a busy cardiac 
catheterization laboratory setting. 
2. The mean total contrast volume used for rotational coronary angiography 
in this study was 22.44 ± 5.16 ml (n = 64). This was significantly less (p < 
0.05) as compared with the mean total contrast volume used for standard 
coronary angiography obtained from unpublished data in Christian Medical 
College, Vellore which was 38.16 ± 7.7 ml (n = 25).  
3. The mean DAP in this study was 20.64 ± 7.18 Gycm2. This was compared 
with data for standard angiography was obtained from previously 
published data from Christian Medical College, Vellore67. The radiation 
dose for standard angiography was 55.86 ± 5.75 Gycm2. The difference 
was statistically significant (p < 0.0001). The 95 % CI of this estimate were 
32.36 – 38.07.  
4. There was a positive correlation of BMI and fluoroscopy time with DAP.  
5. There was a reduction of fluoroscopy time with time and hence a definite 
learning curve was demonstrated. 
6. In patients with LVEF < 50% and/or GFR < 60ml/min/1.73m2, there was no 
significant worsening of GFR after rotational angiography. None of the 
patients developed contrast induced nephropathy. 
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7. Five patients with a baseline GFR > 60ml/min/1.73m2 prior had a decline 
in GFR after angiography. However none of these patients had contrast 
induced nephropathy by definition. Hence, monitoring GFR before and 
after angiography may alert clinicians to early deterioration of renal 
function before an obvious rise in serum creatinine is noticed. 
8. Rotational angiography provided good image quality and adequate 
anatomic information required to plan management, as was assessed by 
the primary operator and a consultant cardiologist. 
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 1
PROFORMA 
 
Assessment of feasibility and utility of rotational coronary angiography in clinical 
practice 
 
S.No:     Date:     
Name:    Hospital No: 
Age:     Sex: 
Wt (kg):    Ht (kg):                     
BMI (kg/m2):     TTD (cm):  
BSA (m2):                                      CTR (%):   
LBW (kg):    
       
    
History of renal disease:  Yes / No   
Prior renal surgery:  Yes / No    
Diabetes Mellitus:  Yes / No   
Hypertension:   Yes / No   
Smoking:   Yes / No   
Dyslipidaemia:   Yes / No   
History of ACS:  Yes / No 
 
Indication for coronary angiography: 
Previous revascularization: PTCA / CABG 
 
Baseline Measurements 
 
Se Creatinine (mg/dl):      
GFR (ml/min/1.73m2) 
• <30   - 
• 30 -59  - 
• ≥60 - 
 
LV EF (%):  
• <30  - 
• 30 – 50 - 
• >50  - 
 
Hemodynamic status: Stable/Unstable 
 
Contrast: 
 
Total Contrast Volume (ml):  
LCA: 
RCA: 
 2
Addittional views: 
 
Renals: 
LV: 
 
Fluoroscopy Time (min):  
 
Cumulative DAP (mGycm2): 
 
Cumulative Air Kerma (mGy): 
 
Post procedure measurements 
 
Se Creatinine (mg/dl): 
GFR (ml/min/1.73m2):  
• <30   - 
• 30 -59  - 
• ≥60 - 
 
Hemodynamic status: Stable/Unstable 
 
Quality of Images: Good/ Not good 
 
Adequacy of images: Adequate/ Not adequate 
 
Coronary Diagnosis: Normal/ Minor/ S/ D/ T/ LD/ LT 
 
Renal Diagnosis: Normal/ Minor/ RAS 
 
 
Adverse Effects: 
 
1. 
2. 
3. 
 
Mortality: Yes/ No 
 
Plan for management: M/ P/ C 
 
 
 
 
  
 
 
 3
Glossary for Master Chart 
 
 
Hosp no     - Hospital number 
Ht      - Height 
Wt      - Weight 
BMI      - Body Mass Index  
LBW      - Lean Body Weight 
BSA      - Body Surface Area 
DM      - Diabetes Mellitus 
HTN      - Hypertension 
DLP      - Dyslipidemia 
ACS      - Acute Coronary Syndrome 
Indication     - Indication for angiography 
Eval      - Evaluation for CAD 
Pre op     - Pre Operative 
Pre Tx     - Pre renal transplant 
TTD      - Trans Thoracic Diameter 
CTR      - Cardio Thoracic Ratio 
GFR1      - Glomerular Filtration Rate (pre angio) 
LVEF1     - Left ventricular ejection fraction 
H Status1       - Hemodynamic status (pre angio)  
S      - Stable 
Contrast     - Contrast used 
O      - Omnipaque 
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V      - Visipaque 
LCA      - Left Coronary Artery 
RCA      - Right Coronary Artery 
addl view     - Additional view 
P Time     - Procedure Time 
F Time     - Fluoroscopy time 
DAP      - Dose Area Product 
GFR 2     - Glomerular Filtration Rate (post angio) 
H Status 2     - Hemodynamic status (post angio) 
S      - Stable 
Adequacy     - Adequacy of anatomic information 
C Diagnosis     - Coronary diagnosis 
N      - Normal 
M      - Minor 
S      - Single Vessel Disease 
D      - Double Vessel Disease 
T      - Triple Vessel Disease 
LD      - Left main triple vessel disease 
LT      - Left main double vessel disease 
R diagnosis     - Renal diagnosis 
RAS      - Renal artery stenosis 
Plan      - Management plan 
M      - Medical 
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P      - PTCA 
C      - CABG 
Y      - Yes 
N      - No 
 
 
 
 
 
 
 
 
SnoDate Name Hosp No Age Sex Ht Wt BMI LBW BSA renal disease
1 16.01.09 Gangadhar Sardar 390316D 55 M 155 68 28.3 50.2 1.67 N
2 17.01.09 Krishnand Jha 004960D 65 M 160 58 22.7 47 1.6 N
3 17.01.09 Sk Taiyeb Mondal 391412D 53 M 163 60 22.6 48.7 1.64 N
4 17.01.09 Magen Thapa 389798D 41 M 171 71 24.3 56 1.83 N
5 17.01.09 Solomon Gebremedhin 387361D 54 M 161 69 26.6 52.4 1.73 N
6 19.01.09 Dhiren Das 389255D 48 M 176 65 21 54 1.8 N
7 19.01.09 Jayram Viswakarma 391452D 54 M 158 64 25.6 49.4 1.65 N
8 19.01.09 Basundhara Biswakarma 389522D 54 F 144 54 26 37 1.44 N
9 19.01.09 Kavitha Gadia 386851D 41 F 155 64 26.4 43.1 1.62 N
10 19.01.09 Sunil Chowdhary 171941D 66 M 164 75 27.9 55.7 1.82 N
11 19.01.09 Sripathi Mondal 384306D 58 M 160 60 23.4 48 1.62 N
12 20.01.09 Dinakaran 061558B 46 M 161 69 26.6 52.4 1.73 N
13 23.01.09 Sadhana Mukherjee 365833D 62 F 155 55 22.9 40.2 1.53 N
14 23.01.09 Eyakat Mollick 392477D 47 M 165 50 18.4 43.3 1.53 N
15 23.01.09 Prabhunath Yadav 188877D 51 M 162 67 25.5 51.8 1.72 Y
16 23.01.09 Surendra Prasad Singh 198509C 63 M 156 54 22.2 44.1 1.52 N
17 24.01.09 Ameer 378176D 57 M 165 65 23.9 51.6 1.72 N
18 24.01.09 Siddheshwar Dutta 392638D 58 M 165 65 23.9 48 1.63 N
19 24.01.09 Ganesh Patra 392830D 60 M 165 65 23.9 51.6 1.72 N
20 24.01.09 Mohit Ranjan Biswas 390496D 62 M 165 65 23.9 51.6 1.72 N
21 24.01.09 Pushpa 005296A 52 F 155 65 27.1 43.5 1.64 N
22 27.01.09 Noor Mohammed 386211D 45 M 179 90 28.1 66.6 2.09 N
23 27.01.09 Sugunamma 184569A 59 F 172 68 23 49.6 1.8 N
24 27.01.09 Ramswaroop Prasad 040202C 66 M 170 69 23.9 54.8 1.8 N
25 28.01.09 Santoshi Prasad 394863D 67 M 150 54 24 42.8 1.48 N
26 28.01.09 Mohan Prasad Gupta 393622D 58 M 170 54 18.7 46.5 1.62 N
27 30.01.09 Akbar Sardar 393810D 59 M 167 45 16.1 40.2 1.48 N
28 30.01.09 Mohelal Verman 276945D 54 M 169 90 31.5 46.3 1.61 N
29 31.01.09 Kanniyan Solomon 390065D 60 M 165 65 23.9 51.6 1.72 N
30 31.01.09 Mira Devi 915453B 48 F 162 73 27.8 54.3 1.78 N
31 02.02.09 Mallika 556788C 56 F 153 60 25.6 41.4 1.57 N
32 09.02.09 Rajendera Prasad Singh 402095D 49 M 165 66 24.2 52.1 1.73 N
33 09.02.09 Murugesan 802859B 59 M 166 89 32.3 61.1 1.97 N
34 09.02.09 Lina Bibi 398313D 48 F 149 67 30.2 41.8 1.61 N
35 09.02.09 Biswanath Verma 401685D 62 M 165 66 24.2 52.1 1.73 N
36 16.02.09 Anjan Kumar Paul 407472D 61 M 170 60 20.8 50.1 1.69 N
37 16.02.09 Prodyut Kumar Dutta 405998D 58 M 165 54 19.8 45.7 1.59 N
38 16.02.09 Kiruba Mani 400048D 57 F 154 56 23.6 40.4 1.53 N
39 23.02.09 Sulochana 807614C 68 F 150 47 20.9 35.8 1.4 N
40 26.02.09 Biswanath Halder 399949D 65 M 160 50 19.5 42.5 1.5 N
41 26.02.09 Dilip Kumar Mondal 408514D 51 M 156 58 23.8 46.1 1.57 N
42 05.03.09 Chandrasekaran 924171C 48 M 170 68 33.5 54.3 1.79 Y
43 05.03.09 Munna Rai 416260D 62 M 170 74 25.6 57.1 1.85 N
44 05.03.09 Nand Kishore Singh 406271D 54 M 168 51 18.1 44.3 1.57 N
45 05.03.09 Sridharan 413017D 52 M 164 58 21.6 47.8 1.63 N
46 05.03.09 Sati Ranjan Das 415721D 68 M 166 47 17.1 53.3 1.76 N
47 09.03.09 Jahar Lal Saha 414442D 57 M 179 64 20 54 1.81 N
48 16.03.09 Ashim Krishna Sarkar 575448D 54 M 160 60 23.4 48 1.62 N
49 16.03.09 Sekar 178353D 58 M 160 84 32.8 57.1 1.87 N
50 16.03.09 Ashok Bouri 421303D 35 M 165 57 20.9 47.4 1.62 N
51 16.03.09 Kalawati Mishra 419667D 62 F 154 66 27.8 43.4 1.64 N
52 16.03.09 Vasu 418660D 52 M 163 65 24.5 51.2 1.7 N
53 16.03.09 Indrajit Kumar Bose 420070D 58 M 162 56 21.3 46.3 1.59 N
54 16.03.09 Anandan 862454A 38 M 179 64 20 54 1.81 N
55 16.03.09 Rajesh Prasad Singh 422331D 49 M 178 79 24.9 61.7 1.97 N
56 16.03.09 Radhakrishnan 365796A 62 M 166 54 19.6 45.8 1.59 N
57 16.03.09 Fatik Chanra Bauri 421301D 48 M 161 59 22.8 47.7 1.62 N
58 23.03.09 Ajit Roy Chowdhury 426909D 58 M 173 50 16.7 44.3 1.59 N
59 23.03.09 Anjali Sen 301267D 64 F 158 71 28.4 46.1 1.73 N
60 23.03.09 Poornam 423577D 48 F 154 57 24 40.7 1.54 N
61 30.03.09 Swapan Kumar Das 430724D 46 M 177 61 19.5 51.9 1.76 N
62 30.03.09 Bhawani Shankar 429652D 65 M 161 58 22.4 47.2 1.61 N
63 30.03.09 Basant Kumar Deo 430266D 49 M 163 70 26.2 53.2 1.75 N
64 30.03.09 Gopal Chandra  Roy 430183D 62 M 165 40 14.7 36.5 1.4 N
renal surgery DM HTN Smoking DLP ACS Indiacation previous TTD CTR Creat 1 GFR 1
N Y N Y N Y Eval N 25.6 46 0.9 93.12
N Y N N N Y Eval N 26.6 48 0.8 103.12
N Y Y Y N N Eval N 23.7 49 1.3 61.38
N N Y N Y Y Eval N 27.6 48 1.2 70.98
N N Y Y N Y Eval N 28.4 51 0.9 113.79
N N N N Y N Eval N 27.5 51 0.9 95.72
N N N N N Y Eval N 26.4 48 1 82.76
N N Y N N N Eval N 22.9 55 1 62.13
N N N N N N Pre op N 23 52 0.7 98.01
N N Y Y N N Eval N 27.8 45 1 79.46
N N N Y N N Pre op N 25.7 49 1.2 65.6
N Y Y N N N Eval N 26.2 46 1.2 69.28
N N N N N N Pre op N 22.9 48 1 59.71
N N N Y N Y Eval N 23.8 55 0.8 110.13
N Y Y N N N Pre Tx N 29.1 57 6.8 9.17
N N Y Y N N Pre op N 28.2 55 0.9 90.58
N Y Y N Y N Eval N 28.2 45 1.2 66.33
N N N Y Y N Eval N 29 38 1.1 73.08
N N N N N N LVD N 30.3 51 1.1 72.57
N Y Y Y N N Eval N 27 40 1.2 65.21
N Y N N Y N Pre op N 25.1 57 0.7 93.4
N N N Y N N Eval N 32.4 49 1.2 69.59
N Y Y N Y N Eval N 24.9 43 0.7 91.03
N Y Y N N Y Eval N 28.4 47 1.1 71.18
N N Y N N N Eval N 24.4 54 1 79.22
N N Y N N N Pre op N 25.8 52 1 81.57
N N N N N N Pre op N 27.9 67 1.1 72.82
N N N N N N Pre op N 30.1 48 0.9 93.46
N Y Y N N Y Eval N 26 52 0.9 91.49
N Y Y N N N Eval N 26.4 58 1.4 57.49
N N Y N N N LVD N 23.7 60 1 60.96
N Y Y Y N N Eval N 27.4 44 1.4 57.25
N Y Y N N Y Eval N 30.9 44 1.2 65.87
N Y Y N N N Eval N 24 55 1 62.9
N N N Y N Y Eval N 31 38 1.4 54.58
N Y Y Y N N Eval N 27 41 1.3 59.65
N N N N N N Eval N 30.2 38 1.2 66.09
N Y Y N Y Y Eval N 26.6 51 1 60.74
N Y Y N N Y Eval N 21 52 0.9 66.18
N N N N N N Pre op N 26.5 69 1.2 64.58
N N Y Y N N Eval N 28.5 49 0.9 94.55
N Y N N N N Pre Tx N 30 50 5.4 12.11
N N N N Y Y Eval N 25.5 58 1.2 65.21
N N N N N N Pre op N 26 51 1 82.76
N Y N Y N N Eval N 28.3 43 1.2 67.58
N N N N N Y Eval N 26.2 53 1.1 70.75
N Y N N Y N LVD N 28.4 55 0.9 94.18
N N Y N N N Eval N 26.7 55 0.9 93.46
N Y Y N N N Eval N 28.9 45 1.2 66.09
N N N N N Y Eval N 27.3 40 0.9 102.06
N Y Y N Y N Eval N 24.3 65 0.7 90.12
N Y Y N Y N Eval N 26.7 56 1 83.4
N N N N N Y Eval Y 29.3 56 1.4 55.32
N N N Y N N Pre op N 30 53 1.1 79.63
N N Y Y N N Eval N 30.3 43 0.9 95.33
N N N N N N Pre op N 25.8 55 1.1 72.09
N N N Y N N Eval N 27.9 51 0.9 95.72
N N Y N N N LVD N 25.7 51 1 81.57
N N Y N N N Eval N 23 58 1.3 43.83
N N N N N N Eval N 25.6 50 0.8 81.37
N Y N Y N Y Eval N 28 46 1.1 76.6
N Y Y Y N Y Eval N 25.8 57 1.2 64.58
N Y Y N Y Y Eval N 29.4 55 1.2 68.4
N N N Y N N LVD N 24.1 56 1.1 72.09
LVEF1 H Status1 Contrast LCA RCA  addl view Volume renals LV Others Total Vol F Time 
45 S O 18 7 0 25 0 0 0 25 2.18
57 S V 12 5 0 17 0 0 0 17 2.07
48 S O 14 5 0 21 0 0 0 21 2
41 S O 14 3 10 27 30 0 0 57 3.1
61 S O 16 5 5 26 15 0 0 41 3.1
52 S O 18 5 0 23 0 0 0 23 2.15
58 S O 15 5 0 20 0 0 0 20 2.5
56 S O 10 4 0 14 15 20 0 49 2.28
45 S O 12 4 0 16 0 40 25 81 1.52
57 S O 18 5 4 27 22 0 0 49 1.52
57 S O 16 4 24 44 0 0 0 44 2.53
57 S O 20 5 0 25 15 20 0 60 1.55
56 S O 12 5 0 17 0 0 25 42 1.07
40 S V 17 5 5 27 0 0 0 27 3.07
56 S V 20 7 0 27 0 0 0 27 1.16
57 S O 16 5 0 21 15 0 0 36 2.23
56 S O 18 5 0 23 15 20 0 58 1.53
58 S O 14 7 0 21 0 0 0 21 1.6
42 S O 18 5 0 23 15 20 0 58 1.6
57 S O 15 5 0 20 15 20 0 55 1.53
58 S O 13 3 0 16 0 0 25 41 2.46
52 S O 15 4 4 23 0 0 0 0 1.47
56 S O 12 4 0 16 15 0 0 31 1.33
57 S O 16 5 0 21 15 0 0 36 2.04
56 S O 14 5 0 19 15 20 0 54 2.04
56 S O 15 5 0 20 0 0 0 20 1.2
52 S O 14 5 5 24 0 20 0 44 1.57
55 S V 16 6 0 22 0 0 25 47 2.55
45 S O 12 5 5 22 0 0 0 22 2.46
57 S V 20 5 5 30 15 20 0 65 3.27
40 S O 12 5 0 17 15 20 0 52 2.27
57 S V 16 5 10 31 15 20 0 66 3.55
30 S O 13 5 0 18 15 20 0 53 2.1
43 S O 11 5 5 21 15 20 0 56 1.57
31 S V 14 3 3 20 0 0 0 20 1.33
57 S O 17 5 5 27 15 20 0 62 1.38
57 S O 14 5 5 24 0 20 0 44 0.53
57 S O 14 5 5 24 15 20 0 59 2.29
57 S O 16 5 5 26 15 20 0 61 1.38
56 S O 16 5 0 21 0 0 25 46 2.05
54 S O 16 5 5 26 15 20 0 61 1.08
55 S V 16 5 0 21 15 20 0 56 0.5
44 S O 16 5 0 21 15 20 0 56 3
57 S O 12 4 0 16 0 0 0 16 0.43
57 S O 13 5 15 33 0 20 0 53 1.16
40 S O 12 5 5 22 15 20 15 72 1.4
32 S V 16 5 0 21 0 0 0 21 1.53
55 S O 14 4 0 18 15 0 0 33 1.14
56 S O 16 6 0 22 15 20 0 57 1.5
44 S O 14 5 0 19 0 20 0 39 0.37
57 S O 14 5 0 19 15 20 0 54 2.01
41 S O 14 5 0 19 15 20 0 54 0.48
40 S V 14 5 20 39 0 0 0 39 1.32
57 S O 18 8 0 26 0 20 25 71 2.04
57 S O 14 5 0 19 15 20 0 54 1.03
52 S O 14 4 0 18 0 20 0 38 1.02
56 S O 14 5 0 19 15 20 0 54 0.51
30 S V 16 5 0 21 0 0 0 21 0.4
55 S V 16 5 0 21 15 0 0 36 1.04
57 S O 16 5 5 26 0 0 0 26 0.43
43 S V 16 5 0 21 0 0 0 21 0.54
35 S V 16 5 0 21 15 0 0 36 1.15
30 S V 16 5 0 21 8 0 0 29 1.15
35 S O 16 5 0 21 0 0 0 21 1.34
DAP Air Kerma Creat 2 GFR 2 H Status 2 Image qual Adequacy Adverse effects Mortality
30.993 412.68 0.9 93.12 S Good Y N N
18.287 246.97 0.9 90.1 S Good Y N N
21.74 284.13 1.3 61.38 S Good Y N N
29.097 385.19 1.3 64.66 S Good Y N N
29.097 385.19 0.9 113.78 S Good Y N N
16.414 226.42 1 84.77 S Good Y N N
26.977 387.68 1.1 74.14 S Good Y N N
17.535 236.12 0.9 70.16 S Good Y N N
17.186 243.43 0.8 84.01 S Good Y N N
17.186 243.43 1.1 71.98 S Good Y N N
27.59 404.02 1.3 59.85 S Good Y N N
21.65 292.67 0.8 110.61 S Good Y N N
14.23 187.67 1 59.71 S Good Y N N
13.396 183.89 0.8 110.13 S Good Y N N
24.343 342.38 Not don Not done S Good Y N N
16.562 225.69 1 80.21 S Good Y N N
22.565 316.766 1.4 55.52 S Good Y N N
12.902 172.31 1 81.57 S Good Y N N
35.047 448.6 1.1 72.57 S Good Y N N
21.178 281.21 0.8 104.11 S Good Y N N
21.525 283.62 0.7 93.4 S Good Y N N
32.616 559.38 1.2 69.59 S Good Y N N
17.679 257 0.6 108.75 S Good Y N N
24.365 391 0.9 89.73 S Good Y N N
20.593 273 1 79.22 S Good Y N N
16.557 219.43 1.2 66.09 S Good Y N N
17.43 229.94 1 81.29 S Good Y N N
28.056 350.746 1 82.76 S Good Y N N
20.467 342.19 0.9 91.49 S Good Y N N
30.22 576 1.2 68.68 S Good Y N N
16.591 231.175 1.4 41.34 S Good Y N N
23.071 350.02 1.4 57.25 S Good Y N N
34.507 471 1.2 65.87 S Good Y N N
33.843 440.42 1.1 56.35 S Good Y N N
15.69 251.61 1 80.47 S Good Y N N
22.874 304.8 1.3 59.65 S Good Y N N
21.024 293.6 1.2 66.09 S Good Y N N
23.367 335.19 0.9 68.59 S Good Y N N
22.874 304.8 0.9 66.18 S Good Y N N
16.652 212.765 1.2 64.58 S Good Y N N
20.466 276.34 0.9 94.55 S Good Y N N
14.87 212.43 NA NA S Good Y N N
38.091 525.92 1.2 65.21 S Good Y N N
9.871 133.18 1.3 61.14 S Good Y N N
14.98 212.15 1 83.4 S Good Y N N
12.181 184.24 1 70.75 S Good Y N N
18.656 264.85 0.9 94.18 S Good Y N N
19.145 260.54 0.9 93.46 S Good Y N N
38.822 635.45 1 81.57 S Good Y N N
14.8 206.7 1 90.38 S Good Y N N
22.381 391.78 0.7 90.12 S Good Y N N
22.036 362.91 1 83.4 S Good Y N N
24.843 338.34 1.2 66.09 S Good Y N N
16.54 230.01 1.1 79.63 S Good Y N N
22.909 314.05 0.9 95.33 S Good Y N N
14.676 209.81 1 80.47 S Good Y N N
15.685 223 0.9 95.72 S Good Y N N
12.139 169.82 1 81.57 S Good Y N N
21.518 317.2 1.3 43.83 S Good Y N N
8.406 114.36 0.9 71.03 S Good Y N N
15.103 206.192 1.3 63.17 S Good Y N N
13.912 180.95 1.2 64.58 S Good Y N N
7.276 396.901 1.4 57.25 S Good Y N N
7.782 106.569 1.1 72.09 S Good Y N N
C Diagnosis R diagnosis Plan
M Not done M
M Not done M
D Not done P
D Minor P
S Normal P
N Not done M
S Not done P
M Normal M
N Not done M
LT Normal C
S Not done C
T RAS C
N Not done M
S Not done P
M Not done M
N Normal M
M Normal M
N Not done M
N Not done M
N Normal M
N Not done M
N Not done M
N Normal M
T Normal C
N Normal M
N Not done M
N Not done M
M Not done M
T Not done C
S Normal P
N Normal M
LT Normal C
D Normal P
T Minor M
LD Not done P
D Normal P
N Not done M
N Normal M
T RAS C
N Not done M
M Normal M
N Normal M
S Normal P
N Not done M
D Not done P
D Not done P
D Not done C
N Normal M
T Normal C
S Not done M
N Normal M
T Normal M
T Not done M
N Not done M
N Normal M
N Not done M
N Not done M
M Not done M
N Normal M
N Not done M
S Normal M
LT Normal C
S Normal M
N Not done M
